POC5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.01959999624313E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.17759999995748E-06 |
Normal-vs-Stage2 |
1.836930E-03 |
Normal-vs-Stage3 |
6.17099999999926E-05 |
Normal-vs-Stage4 |
3.299200E-03 |
Stage1-vs-Stage2 |
5.744400E-01 |
Stage1-vs-Stage3 |
3.847200E-01 |
Stage1-vs-Stage4 |
9.104600E-01 |
Stage2-vs-Stage3 |
8.767200E-01 |
Stage2-vs-Stage4 |
6.303400E-01 |
Stage3-vs-Stage4 |
4.960800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.66760000031019E-07 |
Normal-vs-AfricanAmerican |
1.5168799999965E-05 |
Normal-vs-Asian |
4.38639999988943E-07 |
Caucasian-vs-AfricanAmerican |
8.424000E-01 |
Caucasian-vs-Asian |
8.555900E-03 |
AfricanAmerican-vs-Asian |
2.058200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.59000000002452E-07 |
Normal-vs-Female |
1.30919999952184E-07 |
Male-vs-Female |
1.862960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.395700E-04 |
Normal-vs-Extreme_Weight |
4.44570000035505E-07 |
Normal-vs-Obese |
1.91542999999905E-05 |
Normal-vs-Extreme_Obese |
2.078600E-01 |
Normal_Weight-vs-Extreme_Weight |
3.304000E-01 |
Normal_Weight-vs-Obese |
5.880200E-01 |
Normal_Weight-vs-Extreme_Obese |
2.570800E-01 |
Extreme_Weight-vs-Obese |
6.613400E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.172500E-02 |
Obese-vs-Extreme_Obese |
1.422360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.951000E-04 |
Normal-vs-Age(41-60Yrs) |
1.74109999750982E-08 |
Normal-vs-Age(61-80Yrs) |
3.14489999997392E-06 |
Normal-vs-Age(81-100Yrs) |
4.380400E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.205400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.232400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.108800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.012500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.474000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.030200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.9947999918557E-09 |
Normal-VS-Type2 PRCC |
1.220270E-02 |
Normal-VS-KIRP CIMP |
1.099880E-03 |
Normal-VS-Unclassified PRCC |
1.160350E-04 |
Type1 PRCC-VS-Type2 PRCC |
1.815930E-04 |
Type1 PRCC-VS-KIRP CIMP |
6.110800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
6.007400E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.331200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
3.902300E-02 |
KIRP CIMP-VS-Unclassified PRCC |
8.631600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.36790000000587E-05 |
Normal-vs-N1 |
2.181100E-04 |
Normal-vs-N2 |
8.870100E-02 |
N0-vs-N1 |
2.776800E-01 |
N0-vs-N2 |
7.800000E-01 |
N1-vs-N2 |
4.945800E-01 |
|
|